Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline.

Gormley EA, Lightner DJ, Burgio KL, Chai TC, Clemens JQ, Culkin DJ, Das AK, Foster HE Jr, Scarpero HM, Tessier CD, Vasavada SP; American Urological Association.; Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction..

J Urol. 2012 Dec;188(6 Suppl):2455-63. doi: 10.1016/j.juro.2012.09.079. Epub 2012 Oct 24.

PMID:
23098785
2.

Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment.

Gormley EA, Lightner DJ, Faraday M, Vasavada SP; American Urological Association.; Society of Urodynamics, Female Pelvic Medicine..

J Urol. 2015 May;193(5):1572-80. doi: 10.1016/j.juro.2015.01.087. Epub 2015 Jan 23. Review.

PMID:
25623739
3.

Urodynamic studies in adults: AUA/SUFU guideline.

Winters JC, Dmochowski RR, Goldman HB, Herndon CD, Kobashi KC, Kraus SR, Lemack GE, Nitti VW, Rovner ES, Wein AJ; American Urological Association.; Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction..

J Urol. 2012 Dec;188(6 Suppl):2464-72. doi: 10.1016/j.juro.2012.09.081. Epub 2012 Oct 24.

PMID:
23098783
4.

Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment.

Hanno PM, Erickson D, Moldwin R, Faraday MM; American Urological Association..

J Urol. 2015 May;193(5):1545-53. doi: 10.1016/j.juro.2015.01.086. Epub 2015 Jan 23. Review.

PMID:
25623737
5.

Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline.

Davis R, Jones JS, Barocas DA, Castle EP, Lang EK, Leveillee RJ, Messing EM, Miller SD, Peterson AC, Turk TM, Weitzel W; American Urological Association..

J Urol. 2012 Dec;188(6 Suppl):2473-81. doi: 10.1016/j.juro.2012.09.078. Epub 2012 Oct 24.

PMID:
23098784
6.

Medical management of kidney stones: AUA guideline.

Pearle MS, Goldfarb DS, Assimos DG, Curhan G, Denu-Ciocca CJ, Matlaga BR, Monga M, Penniston KL, Preminger GM, Turk TM, White JR; American Urological Assocation..

J Urol. 2014 Aug;192(2):316-24. doi: 10.1016/j.juro.2014.05.006. Epub 2014 May 20.

PMID:
24857648
7.

Peyronie's Disease: AUA Guideline.

Nehra A, Alterowitz R, Culkin DJ, Faraday MM, Hakim LS, Heidelbaugh JJ, Khera M, Kirkby E, McVary KT, Miner MM, Nelson CJ, Sadeghi-Nejad H, Seftel AD, Shindel AW, Burnett AL; American Urological Association Education and Research, Inc.,..

J Urol. 2015 Sep;194(3):745-53. doi: 10.1016/j.juro.2015.05.098. Epub 2015 Jun 9.

8.

The efficacy of posterior tibial nerve stimulation for the treatment of overactive bladder in women: a systematic review.

Levin PJ, Wu JM, Kawasaki A, Weidner AC, Amundsen CL.

Int Urogynecol J. 2012 Nov;23(11):1591-7. doi: 10.1007/s00192-012-1712-4. Epub 2012 Mar 13. Review.

PMID:
22411208
9.

Pharmacotherapy adherence and costs versus nonpharmacologic management in overactive bladder.

Pelletier EM, Vats V, Clemens JQ.

Am J Manag Care. 2009 Mar;15(4 Suppl):S108-14.

10.

Overactive bladder: diagnosis and management.

Robinson D, Cardozo L.

Maturitas. 2012 Feb;71(2):188-93. doi: 10.1016/j.maturitas.2011.11.016. Epub 2011 Dec 23. Review.

PMID:
22197347
11.

How do urodynamics findings influence the treatment of the typical patient with overactive bladder?

Rutman MP, Cha DY, Blaivas JG.

Curr Urol Rep. 2012 Oct;13(5):370-8. doi: 10.1007/s11934-012-0265-x. Review.

PMID:
22843014
12.

The role of antimuscarinics in the management of men with symptoms of overactive bladder associated with concomitant bladder outlet obstruction: an update.

Athanasopoulos A, Chapple C, Fowler C, Gratzke C, Kaplan S, Stief C, Tubaro A.

Eur Urol. 2011 Jul;60(1):94-105. doi: 10.1016/j.eururo.2011.03.054. Epub 2011 Apr 9. Review.

PMID:
21497434
13.

Efficacy and adverse events of sacral nerve stimulation for overactive bladder: A systematic review.

Siddiqui NY, Wu JM, Amundsen CL.

Neurourol Urodyn. 2010;29 Suppl 1:S18-23. doi: 10.1002/nau.20786. Review.

PMID:
20419795
14.

Medical management of overactive bladder.

Radomski SB, Barkin J.

Can J Urol. 2012 Oct;19 Suppl 1:2-9.

15.

Pelvic organ prolapse and overactive bladder.

de Boer TA, Salvatore S, Cardozo L, Chapple C, Kelleher C, van Kerrebroeck P, Kirby MG, Koelbl H, Espuna-Pons M, Milsom I, Tubaro A, Wagg A, Vierhout ME.

Neurourol Urodyn. 2010;29(1):30-9. doi: 10.1002/nau.20858. Review.

PMID:
20025017
16.

Pediatric overactive bladder syndrome: pathophysiology and management.

Franco I.

Paediatr Drugs. 2007;9(6):379-90. Review.

PMID:
18052408
17.

Urotrauma: AUA guideline.

Morey AF, Brandes S, Dugi DD 3rd, Armstrong JH, Breyer BN, Broghammer JA, Erickson BA, Holzbeierlein J, Hudak SJ, Pruitt JH, Reston JT, Santucci RA, Smith TG 3rd, Wessells H; American Urological Assocation..

J Urol. 2014 Aug;192(2):327-35. doi: 10.1016/j.juro.2014.05.004. Epub 2014 May 20.

18.

Overactive bladder symptoms and voiding dysfunction in neurologically normal women.

Espuña-Pons M, Cardozo L, Chapple C, Sievert KD, van Kerrebroeck P, Kirby MG.

Neurourol Urodyn. 2012 Apr;31(4):422-8. doi: 10.1002/nau.21252. Epub 2012 Mar 14. Review.

PMID:
22419262
19.

Urodynamics in the evaluation of overactive bladder.

Rovner ES, Goudelocke CM.

Curr Urol Rep. 2010 Sep;11(5):343-7. doi: 10.1007/s11934-010-0130-8. Review.

PMID:
20585906
20.

[Diagnosis and treatment of overactive bladder, neurourology, urogynaecology and urinary stress incontinence: latest publications from 2009 and 2010].

Reiter MA, Oeztuerk A, Kurosch M, Haferkamp A.

Urologe A. 2010 Sep;49 Suppl 1:154-62. doi: 10.1007/s00120-010-2373-x. Review. German.

PMID:
20812043

Supplemental Content

Support Center